| None |
AE adverse event |
View
|
| None |
AIDS acquired immunodeficiency syndrome |
View
|
| None |
ALT (SGPT) alanine aminotransferase |
View
|
| None |
ART antiretroviral therapy |
View
|
| None |
AST (SGOT) aspartate aminotransferase |
View
|
| None |
DCF data collection forms |
View
|
| None |
DMC Data Monitoring Committee |
View
|
| None |
FDA (U.S.) Food and Drug Administration |
View
|
| None |
GCP Good Clinical Practice guidelines |
View
|
| None |
HB sAg Hepatitis B surface antigen |
View
|
| None |
ICH International Conference of Harmonization |
View
|
| None |
IND Investigational New Drug Application |
View
|
| None |
IRB Institutional Review Board |
View
|
| None |
IU International units |
View
|
| None |
mg milligram(s) |
View
|
| None |
mm3 cubic millimeter(s) |
View
|
| None |
PCR polymerase chain reaction |
View
|
| None |
SAE serious adverse event |
View
|
| None |
µg microgram |
View
|
| None |
ULN upper limit of the normal range |
View
|
| None |
WB Western Blot |
View
|